Ortho Regenerative Technologies activates half of clinical sites in rotator cuff repair trial
Channel:
Subscribers:
56,400
Published on ● Video Link: https://www.youtube.com/watch?v=FsFVaxz-tTA
Ortho Regenerative Technologies Inc CEO Phillipe Deschamps tells Proactive it has fully activated half of the 10 clinical trial sites involved in its upcoming Phase 1/2 rotator cuff tear repair trial evaluating the company’s novel soft tissue repair regenerative technology.
Sites involved in the study are the Rothman Institute in Pennsylvania, the OrthoIndy Research Foundation in Indiana, University Orthopedics, in Pennsylvania, Tucson Orthopedics in Arizona, and the Holy Cross Orthopedic Institute in Florida, with site activation imminent at the OrthoVirginia Institute in Virginia.
Other Videos By Proactive Investors
Tags:
Investors
investing
investor
economy
stocks
stock market
ftse100
nasdaq
nyse
cse
tsx
tsx-v
otc market
finance
banking
wealth management
asset management
wall street
economics
mining
oil and gas
energy
precious metals
biotech
health
pharma
pharamceutical
cbd
cryptocurrency
bitcoin
blockchain
cannabidoil
cannabis stock
Proactive
ProactiveInvestors
Proactive Investors
shares
trading
money
business
china
china economy
USA
US Economy
EU
European Union
Brexit
YouTube
How To